AMICUS THERAPEUTICS, INC. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Amicus Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Amicus Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -69.5 %, a 52.9% increase year-over-year.
  • Amicus Therapeutics, Inc. annual Return On Equity for 2023 was -119 %, a 15.7% increase from 2022.
  • Amicus Therapeutics, Inc. annual Return On Equity for 2022 was -142 %, a 62.5% decline from 2021.
  • Amicus Therapeutics, Inc. annual Return On Equity for 2021 was -87.2 %, a 7.91% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -119 +22.3 +15.7% Jan 1, 2023 Dec 31, 2023
2022 -142 -54.5 -62.5% Jan 1, 2022 Dec 31, 2022
2021 -87.2 -6.39 -7.91% Jan 1, 2021 Dec 31, 2021
2020 -80.8 -12.2 -17.7% Jan 1, 2020 Dec 31, 2020
2019 -68.7 +7.32 +9.64% Jan 1, 2019 Dec 31, 2019
2018 -76 +8.79 +10.4% Jan 1, 2018 Dec 31, 2018
2017 -84.8 -25.2 -42.2% Jan 1, 2017 Dec 31, 2017
2016 -59.6 -14 -30.8% Jan 1, 2016 Dec 31, 2016
2015 -45.6 +72.8 +61.5% Jan 1, 2015 Dec 31, 2015
2014 -118 +26 +18% Jan 1, 2014 Dec 31, 2014
2013 -144 -79.4 -122% Jan 1, 2013 Dec 31, 2013
2012 -65.1 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.